Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

77,534 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants.
Wang K, Jia Z, Bao L, Wang L, Cao L, Chi H, Hu Y, Li Q, Zhou Y, Jiang Y, Zhu Q, Deng Y, Liu P, Wang N, Wang L, Liu M, Li Y, Zhu B, Fan K, Fu W, Yang P, Pei X, Cui Z, Qin L, Ge P, Wu J, Liu S, Chen Y, Huang W, Wang Q, Qin CF, Wang Y, Qin C, Wang X. Wang K, et al. Among authors: liu m, liu s, liu p. Nature. 2022 Mar;603(7903):919-925. doi: 10.1038/s41586-022-04466-x. Epub 2022 Jan 28. Nature. 2022. PMID: 35090164 Free PMC article.
Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds.
Cui Z, Luo W, Chen R, Li Y, Wang Z, Liu Y, Liu S, Feng L, Jia Z, Cheng R, Tang J, Huang W, Zhang Y, Liu H, Wang X, Li W. Cui Z, et al. Among authors: liu y, liu h, liu s. Signal Transduct Target Ther. 2023 May 4;8(1):179. doi: 10.1038/s41392-023-01422-7. Signal Transduct Target Ther. 2023. PMID: 37142583 Free PMC article.
Deletion of V483 in the spike confers evolutionary advantage on SARS-CoV-2 for human adaptation and host-range expansion after a prolonged pandemic.
Yue C, Liu S, Meng B, Fan K, Yang S, Liu P, Zhu Q, Mao X, Yu Y, Shao F, Wang P, Wang Y, Gupta RK, Cao Y, Wang X. Yue C, et al. Among authors: liu s, liu p. Cell Res. 2024 Oct;34(10):739-742. doi: 10.1038/s41422-024-01000-8. Epub 2024 Jul 19. Cell Res. 2024. PMID: 39030295 Free PMC article. No abstract available.
Omicron escapes the majority of existing SARS-CoV-2 neutralizing antibodies.
Cao Y, Wang J, Jian F, Xiao T, Song W, Yisimayi A, Huang W, Li Q, Wang P, An R, Wang J, Wang Y, Niu X, Yang S, Liang H, Sun H, Li T, Yu Y, Cui Q, Liu S, Yang X, Du S, Zhang Z, Hao X, Shao F, Jin R, Wang X, Xiao J, Wang Y, Xie XS. Cao Y, et al. Among authors: liu s. Nature. 2022 Feb;602(7898):657-663. doi: 10.1038/s41586-021-04385-3. Epub 2021 Dec 23. Nature. 2022. PMID: 35016194 Free PMC article.
The antigenicity of SARS-CoV-2 Delta variants aggregated 10 high-frequency mutations in RBD has not changed sufficiently to replace the current vaccine strain.
Wu J, Nie J, Zhang L, Song H, An Y, Liang Z, Yang J, Ding R, Liu S, Li Q, Li T, Cui Z, Zhang M, He P, Wang Y, Qu X, Hu Z, Wang Q, Huang W. Wu J, et al. Among authors: liu s. Signal Transduct Target Ther. 2022 Jan 19;7(1):18. doi: 10.1038/s41392-022-00874-7. Signal Transduct Target Ther. 2022. PMID: 35046385 Free PMC article.
77,534 results
You have reached the last available page of results. Please see the User Guide for more information.